Access To Medicine Foundation

Often searched

Index ranking

Vacancies

10 year analysis

  • Healthcare inequity
    • How big is the problem?
    • How we drive change
    • Our story
    • Our impact
    • How big is the problem?
    • How we drive change
    • Our story
    • Our impact
  • Become a catalyst
    • Investors
    • Companies
    • Government & policymakers
    • Events & engagements
    • Investors
    • Companies
    • Government & policymakers
    • Events & engagements
  • Sectors and research
    • R&D-based pharma companies
    • Medical gas companies
    • Generic medicine manufacturers
    • Diagnostics companies
    • Vaccine manufacturers
    • Research hub
    • Company profiles & report cards
    • R&D-based pharma companies
    • Medical gas companies
    • Generic medicine manufacturers
    • Diagnostics companies
    • Vaccine manufacturers
    • Research hub
    • Company profiles & report cards
  • Cross-Sector Programmes
    • Antimicrobial resistance
    • Diabetes care
    • Antimicrobial resistance
    • Diabetes care
  • On the pulse of global health
    • Access insights
    • The Health Equity podcast
    • Access insights
    • The Health Equity podcast
  • News
  • Our team
  • Featured insights
  • Governance & financials
  • Vacancies
  • Media coverage
  • FAQ
  • Contact us

World AMR Congress: Access to Medicine Foundation to speak on access strategies and responsible manufacturing

The Access to Medicine Foundation's Director of Government Engagement and Policy, Margo Warren, and Researcher, Martijn van Gerven, will be at the World AMR Congress, where they will discuss steps companies can take to help curb antimicrobial resistance (AMR) – drawing on insights from the Foundation's recently published report on Responsible Manufacturing.

Date

07 September 2023

Date

7 - 8 September 2023

Location

Philadelphia, USA

AMR kills millions of people worldwide each year, and this global health threat is rising faster than predicted. This requires urgent action, including understanding and addressing the various drivers of drug resistance. 

The Foundation has been tracking company action to address AMR for several years, as well as guiding and stimulating companies to make progress on multiple fronts – from antibiotics and antifungals R&D, to expanding access to much-needed products in low- and middle-income countries, to responsible manufacturing of antibiotics. At the Congress, Margo and Martijn will bring these insights to discussions on key topics, joining other experts and high-level speakers in Philadelphia for the two-day event. 

Since its inception in 2015, the World AMR Congress – which draws more than 1,300 participants – has served as a global nexus for AMR stakeholders to collaborate, innovate, and devise strategies to combat antimicrobial resistance. 

Preserving solutions: responsible antibiotic access strategies 

Margo will speak as a keynote panelist on "Preserving solutions: responsible antibiotic access strategies".  The event will take place from 4:20pm to 5:00pm on 7 September. Other panelists include: 

  • Melissa Gong Mitchell, Secretariat Lead, AMR Industry Alliance (Moderator) 

  • Boumediene Soufi, Global Head AMR, Sandoz 

  • Mirfin Mpundu, Director, React Africa 

  • Yann Ferrisse, Director, Business Development & Partner Engagement, GARDP 

Providing access to antibiotics while preventing AMR: How can companies behave and manufacture responsibly? 

Martijn will engage in a fireside chat on “Providing access to antibiotics while preventing AMR: How can companies behave and manufacture responsibly?” from 11:20am - 11:40am on 7 September.  

Martijn, who is a researcher on the Foundation’s AMR Programme, will draw from the Foundation’s recently published report on Responsible Manufacturing.

Joining him in the conversation will be Anthony McDonnell from the Center for Global Development (CGD).

Cross-sector programmes

Learn more about our work on antimicrobial resistance
Research

Lack of access to generic antibiotics and antifungals is an overlooked issue in AMR

22 November 2022
Research

Lack of access to medicine is a major driver of drug resistance. How can pharma take action?

27 October 2022
News

What are pharma companies doing to slow the superbugs?

02 November 2021

Access to Medicine Foundation

Interested in our work?

Access to Medicine Foundation is funded by

Terms & conditions

Privacy & cookie policy

Disclaimer

Copyright 2004 - 2025 Access to Medicine Foundation - All Rights Reserved